Cardiovascular Clinical Project to Evaluate the Regenerative Capacity of CardioCell in Patients With Acute Myocardial Infarction (AMI)

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 105 participants.

Also called NCT03404063

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 2/3
Enrolled
  • 105 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03404063
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Poland (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03404063. Randomized; quadruple masking; primary purpose treatment. Start 2017-10-20 (actual); primary completion 2020-07-02 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Cardiovascular Clinical Project to Evaluate the Regenerative Capacity of CardioCell in Patients With Acute Myocardial Infarction (AMI)
Intervention (Drug)
Cardiac Drug
Intervention (Drug)
Placebos
Lead sponsor
John Paul II Hospital, Krakow (class: other)
Collaborator
KCRI (class: other)
Collaborator
National Center for Research and Development, Poland (class: other)

Record details

Record id
cardio:ct-nct03404063
Content hash
850629fc0af188799b0cf0e566c864a04667833cfee96fbfad567fdd4b738c24